key: cord-0960606-0mzgowcy
authors: Konstantinidis, Ioannis; Kitsios, Georgios D.; Morris, Alison
title: The Impact of Acute Illness Severity on Post–COVID-19 Sequelae Remains an Unsettled Question
date: 2021-03-30
journal: Annals of the American Thoracic Society
DOI: 10.1513/annalsats.202102-189le
sha: 8b87f4be8452ee1d15bfa7ea5e9f94fefc621374
doc_id: 960606
cord_uid: 0mzgowcy

nan

physiologic and functional impairments (2, 3) . According to the study by Townsend and colleagues, all patients diagnosed with COVID-19 should be followed for persistent symptoms and impairments regardless of the severity of the initial infection (4), a message with substantial implications for the design of post-COVID-19 follow-up programs in outpatient clinics. However, we posit that some important methodological and analytical issues may account for this counterintuitive result.

First, we are concerned about the possibility of selection bias in the subset of participants that presented for follow-up visits. In contrast to other studies that followed discharged inpatients only (2, 3), Townsend and colleagues offered follow-up appointments to both inpatients and outpatients. However, the proportions of appointment acceptance between the two groups are strikingly different: 63% (74/118) for inpatients versus 21% (79/369) for outpatients (P , 0.0001 for comparison of proportions). The probability of accepting the invitation may have been biased in different ways in each group, diminishing the authors' ability to detect differences based on disease severity. For example, the 63% of contacted inpatients who were willing and functionally able to physically attend a clinic appointment (rather than a telemedicine visit) may have been less impaired compared with the 37% of inpatients who did not or could not accept an appointment. Conversely, it is possible that the 21% of contacted outpatients who attended the follow-up visit were motivated to do so because of concerns about persistent symptoms and limitations.

Combined with the small sample size of inpatients (especially of the intensive care unit cohort), and lack of telephone follow-up, such differential representation of symptom burden between inpatients and outpatients could mask any effects of acute illness severity.

Second, the reported conclusion of lack of association between radiographic abnormalities and initial disease severity is somewhat perplexing. Abnormal chest radiographs were found in 19% of inpatients, but no outpatients (P value of ,0.001 for comparison of proportions), suggesting an association between abnormal chest radiography and acute illness severity. In addition, we note that the proportion of abnormal chest radiographs among inpatients was comparable to the proportion reported for hospitalized patients in London (13%) (3) . These results contrast with the much higher frequency of computedtomography abnormalities in theLondon (75%) and Wuhan (53%) cohorts (2, 3) , highlighting the limited sensitivity of chest radiography in patients despite high burden of symptoms and functional limitations.

The study by Townsend and colleagues reports important early observations, yet the lack of association between acute illness severity and medium-term impairments should be interpreted with caution in view of possible selection bias, small sample size concerns, and lack of sensitivity of chest radiographs. It remains a priority to risk stratify survivors of COVID-19 for dedicated clinical follow-up programs and targeted interventions to mitigate the long-term personal and societal impact of this devastating syndrome.

Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia

4 questions about COVID-19 severity and persistent outcomes